Is Erectile Dysfunction A Side Effect Of Taking Weight-Loss Drugs?
Erectile dysfunction (ED) can be a possible side effect of some modern weight‑loss drugs, especially the GLP‑1–based ones such as semaglutide (Ozempic, Wegovy) and similar agents, though the risk is relatively small and not universal.
Which weight‑loss drugs are linked?
-
Semaglutide (used for obesity and type‑2 diabetes) has been associated in observational studies with a higher risk of newly diagnosed erectile dysfunction and testosterone deficiency in non‑diabetic obese men, compared with matched controls not taking the drug.
-
Drug‑label information and emerging research note “sexual dysfunction” as a possible adverse effect, even though the most common side effects are gastrointestinal (nausea, vomiting, diarrhea, constipation).
How strong is the risk?
-
The absolute proportion of users developing ED appears low (roughly low‑single‑digit percentages in some cohorts), but the relative risk is meaningfully higher than in non‑users.
-
Mechanisms may include changes in testosterone signaling, rapid fat‑mass loss, and effects on blood‑flow regulation, though the exact pathways are still being studied.
Is ED the only issue?
-
Some men report reduced libido or sexual desire along with ED, sometimes linked to lower testosterone levels while on these drugs.
-
On the other hand, overall weight loss (via diet or other safer methods) tends to improve erectile function and sexual health in obese men, so the net effect depends on the drug, dose, and individual biology.
What should you do if you are on such drugs?
-
Do not stop prescribed medication abruptly; discuss any new or worsening ED with your doctor, who can check testosterone, blood‑sugar control, blood pressure, and other contributing factors.
-
Your physician may adjust the dose, temporarily pause the drug, or add symptomatic treatment (such as phosphodiesterase‑5 inhibitors) if ED is confirmed and deemed clinically significant.
